IO360° 2024: Combining Radiopharmaceuticals with Immunotherapy
Learn about Invicro’s portfolio of preclinical and clinical immuno-oncology (IO) capabilities at IO360° meeting booth #24! Fueled by our advanced technology solutions, we have supported the full spectrum of therapeutic modalities – our expertise extends to combining radiopharmaceuticals with immunotherapy and optimizing the development of targeted therapies like antibody drug conjugates.
Your Late Phase Imaging Biomarker Partner!
Join us at booth #814 to explore how Invicro’s global clinical imaging core lab has successfully supported 600+ clinical trials driven by scientific and operational excellence, guided by project management expertise, and amplified by extracting crucial data with advanced analytics and artificial intelligence.
- 3,500+ Research Trials Managed
- 535+ Clinical Trials Managed
- 40,000,000+ (DICOM) Images Processed
- 800+ Molecules Labeled
CNS Webinar Series
Discover our capabilities from in vitro assays to in vivo imaging using PET, SPECT and MRI imaging biomarkers in CNS drug development and CNS clinical trials.Watch Now
Oncology Webinar Series
Gain insights on ground-breaking techniques and imaging methods in preclinical through late-phase oncology studies.Watch Now